Department of Physiology, School of Basic Medical Science, Central South University, Changsha, 410078, Hunan, China.
Department of Physiology, Hunan University of Medicine, Huaihua, China.
J Transl Med. 2023 Mar 6;21(1):179. doi: 10.1186/s12967-023-04027-4.
Necroptosis of macrophages is a necessary element in reinforcing intrapulmonary inflammation during acute lung injury (ALI). However, the molecular mechanism that sparks macrophage necroptosis is still unclear. Triggering receptor expressed on myeloid cells-1 (TREM-1) is a pattern recognition receptor expressed broadly on monocytes/macrophages. The influence of TREM-1 on the destiny of macrophages in ALI requires further investigation.
TREM-1 decoy receptor LR12 was used to evaluate whether the TREM-1 activation induced necroptosis of macrophages in lipopolysaccharide (LPS)-induced ALI in mice. Then we used an agonist anti-TREM-1 Ab (Mab1187) to activate TREM-1 in vitro. Macrophages were treated with GSK872 (a RIPK3 inhibitor), Mdivi-1 (a DRP1 inhibitor), or Rapamycin (an mTOR inhibitor) to investigate whether TREM-1 could induce necroptosis in macrophages, and the mechanism of this process.
We first observed that the blockade of TREM-1 attenuated alveolar macrophage (AlvMs) necroptosis in mice with LPS-induced ALI. In vitro, TREM-1 activation induced necroptosis of macrophages. mTOR has been previously linked to macrophage polarization and migration. We discovered that mTOR had a previously unrecognized function in modulating TREM-1-mediated mitochondrial fission, mitophagy, and necroptosis. Moreover, TREM-1 activation promoted DRP1 phosphorylation through mTOR signaling, which in turn caused surplus mitochondrial fission-mediated necroptosis of macrophages, consequently exacerbating ALI.
In this study, we reported that TREM-1 acted as a necroptotic stimulus of AlvMs, fueling inflammation and aggravating ALI. We also provided compelling evidence suggesting that mTOR-dependent mitochondrial fission is the underpinning of TREM-1-triggered necroptosis and inflammation. Therefore, regulation of necroptosis by targeting TREM-1 may provide a new therapeutic target for ALI in the future.
巨噬细胞的坏死性凋亡是急性肺损伤(ALI)期间增强肺内炎症的必要因素。然而,引发巨噬细胞坏死性凋亡的分子机制尚不清楚。髓样细胞触发受体-1(TREM-1)是广泛表达于单核细胞/巨噬细胞上的一种模式识别受体。TREM-1 对 ALI 中巨噬细胞命运的影响需要进一步研究。
使用 TREM-1 诱饵受体 LR12 来评估 LPS 诱导的 ALI 中 TREM-1 的激活是否诱导巨噬细胞坏死性凋亡。然后,我们使用激动型抗-TREM-1 Ab(Mab1187)在体外激活 TREM-1。用 GSK872(RIPK3 抑制剂)、Mdivi-1(DRP1 抑制剂)或雷帕霉素(mTOR 抑制剂)处理巨噬细胞,以研究 TREM-1 是否能诱导巨噬细胞发生坏死性凋亡,以及该过程的机制。
我们首先观察到,阻断 TREM-1 可减轻 LPS 诱导的 ALI 中小鼠肺泡巨噬细胞(AlvMs)的坏死性凋亡。在体外,TREM-1 的激活诱导了巨噬细胞的坏死性凋亡。mTOR 先前与巨噬细胞极化和迁移有关。我们发现,mTOR 在调节 TREM-1 介导的线粒体裂变、线粒体自噬和坏死性凋亡方面具有以前未知的功能。此外,TREM-1 激活通过 mTOR 信号促进 DRP1 磷酸化,进而导致过量的线粒体分裂介导的巨噬细胞坏死性凋亡,从而加重 ALI。
在这项研究中,我们报道 TREM-1 作为 AlvMs 的坏死性凋亡刺激物,促进炎症并加重 ALI。我们还提供了有力的证据表明,mTOR 依赖性线粒体裂变是 TREM-1 触发的坏死性凋亡和炎症的基础。因此,通过靶向 TREM-1 调节坏死性凋亡可能为未来的 ALI 提供新的治疗靶点。